BlueCrest Capital Management’s Select Medical SEM Stock Holding History

BlueCrest Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-28,640	Closed	-$280K	–	1764
2018 Q2	$280K	Buy	+28,640	New	+$281K	0.01%	1147
2018 Q1	–	Sell	-47,653	Closed	-$453K	–	1614
2017 Q4	$453K	Buy	+47,653	New	+$455K	0.01%	546
2015 Q1	–	Sell	-32,294	Closed	-$251K	–	734
2014 Q4	$251K	Buy	+32,294	New	+$236K	0.01%	508

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BlueCrest Capital Management's SEM Position: Q3 2018 in Review

BlueCrest Capital Management sold out of Select Medical (SEM) in Q3 2018, closing a stake of 28,640 shares — an estimated $280K sold.

BlueCrest Capital Management first reported a position in SEM in Q4 2014 and held it in 3 quarters. The position peaked at $453K in Q4 2017. 197 funds tracked by Wall St. Rank hold SEM as of Q3 2018.

BlueCrest Capital Management reported no remaining Select Medical position as of Q3 2018 after selling out during the quarter.
BlueCrest Capital Management sold 28,640 Select Medical shares in Q3 2018, an estimated $280K.
BlueCrest Capital Management first reported a position in Select Medical in Q4 2014 and held it in 3 quarters.
BlueCrest Capital Management's Select Medical position peaked at $453K in Q4 2017.
197 funds tracked by Wall St. Rank held Select Medical as of Q3 2018.

Based on BlueCrest Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.